Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Ph 1 Study of ADI-PEG 20 Plus Low Dose Cytarabine in Older Patients With AML
ClinicalTrials.gov study NCT02875093. IPD Sharing: Not stated. Countries: 1. Publications: 1.
First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients
ClinicalTrials.gov study NCT05601726. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies
ClinicalTrials.gov study NCT05453903. IPD Sharing: YES. Countries: 8. Publications: 1.
FLAG+Ida With G-CSF Priming for Patients Younger Than 60 Years With Resistant AML
ClinicalTrials.gov study NCT00559221. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vinblastine for Leukoreduction in Newly Diagnosed AML and Hyperleukocytosis
ClinicalTrials.gov study NCT05062278. IPD Sharing: NO. Countries: 1. Publications: 5.
First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL),
ClinicalTrials.gov study NCT05086315. IPD Sharing: YES. Countries: 5. Publications: 0.
Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation
ClinicalTrials.gov study NCT02632708. IPD Sharing: YES. Countries: 3. Publications: 4.
Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML
ClinicalTrials.gov study NCT05177731. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose Cytarabine
ClinicalTrials.gov study NCT00995332. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML.
ClinicalTrials.gov study NCT06483906. IPD Sharing: NO. Countries: 1. Publications: 11.
Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00079482. IPD Sharing: Not stated. Countries: 13. Publications: 1.
A Phase II Study of Vibecotamab (XmAb14045) for MRD- Positive AML and MDS After Hypomethylating Agent Failure
ClinicalTrials.gov study NCT05285813. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of ARGX-110 in Combination With Azacytidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) or High Risk Myelodysplatic Syndrome (MDS)
ClinicalTrials.gov study NCT03030612. IPD Sharing: UNDECIDED. Countries: 2. Publications: 1.
Study of APVO436 in Patients With AML or MDS
ClinicalTrials.gov study NCT03647800. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Use of the MiCK Assay for Apoptosis in AML
ClinicalTrials.gov study NCT00286845. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Immunophenotyping and Xist Gene in AML
ClinicalTrials.gov study NCT04288739. IPD Sharing: UNDECIDED. Countries: 1. Publications: 9.
Precision Therapy Versus Standard Therapy in AML and MDS in Elderly
ClinicalTrials.gov study NCT05025098. IPD Sharing: NO. Countries: 1. Publications: 32.
Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT
ClinicalTrials.gov study NCT01810120. IPD Sharing: NO. Countries: 1. Publications: 29.
CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory AML or MDS
ClinicalTrials.gov study NCT04017546. IPD Sharing: NO. Countries: 1. Publications: 1.
Evaluation of "Dose-dense Therapy" by S-HAM in Comparison to Conventionally Timed Double Induction in Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01382147. IPD Sharing: Not stated. Countries: 1. Publications: 6.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.